Misplaced Pages

Tiadenol

Article snapshot taken from[REDACTED] with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.

This is an old revision of this page, as edited by CheMoBot (talk | contribs) at 08:26, 1 September 2011 (Updating {{drugbox}} (changes to watched fields - updated 'ChEMBL_Ref', 'ChEBI_Ref', 'ChEBI_Ref') per Chem/Drugbox validation (report errors or bugs)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Revision as of 08:26, 1 September 2011 by CheMoBot (talk | contribs) (Updating {{drugbox}} (changes to watched fields - updated 'ChEMBL_Ref', 'ChEBI_Ref', 'ChEBI_Ref') per Chem/Drugbox validation (report errors or bugs))(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff) Pharmaceutical compound
Tiadenol
Clinical data
Other names2-({10-decyl}sulfanyl)ethan-1-ol
AHFS/Drugs.comInternational Drug Names
ATC code
Identifiers
IUPAC name
  • 2,2'-diethanol
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
CompTox Dashboard (EPA)
ECHA InfoCard100.027.423 Edit this at Wikidata
Chemical and physical data
FormulaC14H30O2S2
Molar mass294.519 g/mol g·mol
3D model (JSmol)
SMILES
  • OCCSCCCCCCCCCCSCCO
InChI
  • InChI=1S/C14H30O2S2/c15-9-13-17-11-7-5-3-1-2-4-6-8-12-18-14-10-16/h15-16H,1-14H2
  • Key:WRCITXQNXAIKLR-UHFFFAOYSA-N
  (verify)

Tiadenol is a hypolipidemic agent.


Lipid-lowering agents (C10)
GI tract
Cholesterol absorption inhibitors, NPC1L1
Bile acid sequestrants/resins (LDL)
Liver
Statins (HMG-CoA reductase, LDL)
Niacin and derivatives (HDL and LDL)
MTTP inhibitors (VLDL)
ATP citrate lyase inhibitors (LDL)
Thyromimetics (VLDL)
Blood vessels
PPAR agonists (LDL)
Fibrates
Others
CETP inhibitors (HDL)
PCSK9 inhibitors (LDL)
ANGPTL3 inhibitors (LDL/HDL)
Combinations
Other


Stub icon

This drug article relating to the cardiovascular system is a stub. You can help Misplaced Pages by expanding it.

Categories:
Tiadenol Add topic